The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
In Vitro Characterization of Conditions for Amyloid-β Peptide Oligomerization and Fibrillogenesis
Open accessAbstract
Extensive research causally links amyloid-beta peptide (A beta) to Alzheimer's disease, although the pathologically relevant A beta conformation remains unclear. A beta spontaneously aggregates into the fibrils that deposit in senile plaques. However, recent in vivo and in vitro reports describe a potent biological activity for oligomeric assemblies of A beta. To consistently prepare in vitro oligomeric and fibrillar forms of A beta 1-42, a detailed knowledge of how solution parameters influence structure is required. This manuscript represents the first study using a single chemically and structurally homogeneous unaggregated starting material to demonstrate that the formation of oligomers, fibrils, and fibrillar aggregates is determined by time, concentration, temperature, pH, ionic strength, and A beta species. We recently reported that oligomers inhibit neuronal viability 10-fold more than fibrils and approximately 40-fold more than unaggregated peptide, with oligomeric A beta 1-42-induced neurotoxicity significant at 10 nm. In addition, we were able to differentiate by structure and neurotoxic activity wild-type A beta1-42 from isoforms containing familial mutations (Dahlgren, K. N., Manelli, A. M., Stine, W. B., Jr., Baker, L. K., Krafft, G. A., and LaDu, M. J. (2002) J. Biol. Chem. 277, 32046-32053). Understanding the biological role of specific A beta conformations may define the link between A beta and Alzheimer's disease, re-focusing therapeutic approaches by identifying the pernicious species of A beta ultimately responsible for the cognitive dysfunction that defines the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The 48 h total incubation leads to mature Aβ42 fibrils, as observed by TEM (Figure 10, panel a) while the Western blot shows the presence of higher order Aβ42 oligomers (Figure 10, lane a), likely due to an assembly-disassembly equilibrium that is established for mature Aβ fibrils.89–91”
From Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ42Peptide (2012) · cites this paper as [91]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In addition, the MOAB-2-based oA42 ELISA detects oligomeric but not monomeric A42 using synthetic preparations characterized previously by our laboratory (data not shown) (47,48).”
From APOE4-specific Changes in Aβ Accumulation in a New Transgenic Mouse Model of Alzheimer Disease (2012) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Self-citationImmunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M., & Stefani, M. (2002) · Nature · doi:10.1038/416507a · Cited by 2,434
Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757
Conway, K. A., Lee, S., Rochet, J., Ding, T. T., Williamson, R. E., & Lansbury, P. T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.571 · Cited by 1,559
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530
Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils
Götz, J., Chen, F., van Dorpe, J., & Nitsch, R. M. (2001) · Science · doi:10.1126/science.1062097 · Cited by 1,526
Flagged first, then by citations
Research works printed but not linked: 3
- Hou, 2002, J. Biol. Chem., 26, 26
- DePace, 2002, Nat. Struct. Biol., 9, 389
- Fezoui, 2002, J. Biol. Chem., 30, 30
Cited by
Sorted by citations
Items 901–999 of 999
Borghys, H., Schwab, A. J., & Keppler, B. R. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39104 · Cited by 1
Trehalose, but not other sugars, protects HT22 cells against amyloid-beta toxicity
Xu, Y., Singh, K., Beazely, M. A., & Leonenko, Z. (2025) · Brain Organoid and Systems Neuroscience Journal · doi:10.1016/j.bosn.2025.04.005 · Cited by 1
Sayar, P., Maral, M., Yildiz, E., & Erdem, A. (2025) · Electroanalysis · doi:10.1002/elan.12049 · Cited by 1
Liu, Y., Ning, Z., Dai, Q., Zhang, X., Xiao, Y., Zhang, Z., Guo, D., Chen, J., Li, Y., Li, W., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.08.024 · Cited by 1
Zhao, J., Chen, J., Lu, J., Shi, Q., Wang, Q., Gao, Z., Zeng, L., & Liu, Q. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70218 · Cited by 1
Brossaud, R., Moullé, V. S. F., Giblaine, M., Even, S., Maillard, M.-B., Chevalier, S., Oullier, T., Guédon, É., Loir, Y. L., Cissé, M., et al. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.107095 · Cited by 1
Astrocytic TPK1 mitigates amyloid pathology via TFEB-mediated endocytosis
Zhang, S.-Z., Ma, Y., Ding, Y., Yin, Y., Wang, B., Hu, G., & Zhou, J.-W. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115640 · Cited by 1
Kumar, V., Tom, M., Santhosini, R. M., Begam, R., Jayashree, S., & Jaimohan, S. M. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.109539 · Cited by 2
Unmasking the hidden catalyst: How infections trigger Alzheimer's disease
Fülöp, T., Cohen, A. A., Frost, E. H., Lévesque, S., Khalil, A., Rodrigues, S., Desroches, M., Alami, M., Berrougui, H., Ramassamy, C., et al. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877251415571 · Cited by 2
Pyk2 plays a critical role in synaptic dysfunction during the early stages of Alzheimer’s disease
Rodriguez, Q., Payet, F., Vargas-Baron, K., Borel, E., Lanté, F., Boisseau, S., Blot, B., Girault, J., & Buisson, A. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00021-4 · Cited by 1
Neurotoxicity of the Alzheimer’s β-Amyloid Peptide
Howlett, D. R. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-888-5_6 · Cited by 1
Piruzyan, L. A., & Leksina, L. A. (2009) · Human Physiology · doi:10.1134/s0362119709010150 · Cited by 1
BASP1 – an Axon Terminal Protein Forming Amyloid-Like Oligomers
Vityuk, O. S., Giliano, N. Y., & Zakharov, V. V. (2015) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-015-0105-9 · Cited by 1
Fibrillogenesis in ADan peptides is inhibited by biphenyl ethers
Surolia, I., Chhibber, M., Sarkar, D. P., & Sinha, S. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.04.015 · Cited by 1
Amyloid β-protein oligomers and Alzheimer's
Hayden, E. Y., & Teplow, D. B. (2013) · Cited by 1
Usery, S. E. (2014) · IRL - University of Missouri, St. Louis (University of Missouri–St. Louis) · Cited by 1
Analogue and conformational studies on peptides, hormones and other biologically active peptides
Penke, B., Tóth, G. K., & Váradi, G. (2007) · Royal Society of Chemistry eBooks · doi:10.1039/b710350f · Cited by 1
Beneficial Effects of Citrus Flavonoids Against Aβ Pathology in Alzheimer’s Disease
Javed, H., Ojha, S. K., & Jamali, M. C. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_19 · Cited by 1
TRPM2 in the Central Nervous System: Physiological Role and Critical Regulatory Pathways
Belrose, J. C. (2012) · Scholarship@Western (Western University) · Cited by 1
Amyloid-β As a Biologically Active Peptide in CNS
Gamkrelidze, G. N., Yun, S. H., & Trommer, B. L. (2006) · Springer eBooks · doi:10.1007/0-387-25443-9_30 · Cited by 1
Amyloid Fibril Formation of Natively Unfolded Proteins
Uversky, V. N., & Fink, A. L. (2008) · Wiley eBooks · doi:10.1002/9783527610754.md15 · Cited by 1
Development of molecular recognition by rational and combinatorial engineering
Jonsson, A. (2009) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 1
Interaction of Alzheimer Amyloid Peptide with Cell Surfaces and Artificial Membranes
Bateman, D. A., & Chakrabartty, A. (2011) · Wiley eBooks · doi:10.1002/9783527634323.ch11 · Cited by 1
Sum frequency generation spectroscopy of amyloid fibrils and oligomers at air/water interface
Niaura, G., Budvytytė, R., Kuprionis, Z., & Valinčius, G. (2010) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.871042 · Cited by 2
Apolipoprotein E: Structural and Functional Interactions with Amyloid β
Stine, W. B., & LaDu, M. J. (2005) · Wiley eBooks · doi:10.1002/9783527619344.ch10 · Cited by 1
Self-citationYeast as a Model for Studying Aβ Aggregation, Toxicity and Clearance
Bharadwaj, P. (2011) · Australasian Journal of Paramedicine · Cited by 1
Reif, B., & Narayanan, S. (2006) · Springer eBooks · doi:10.1007/128_066 · Cited by 1
Krupa, J. M., Medapati, M. R., Tsang, A. R., Seah, C., & Pasternak, S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.02.641073 · Cited by 1
Excess Met1-ubiquitination leads to solid aggregate formationPreprint
Kaypee, S., Miyasaka, M., NAKAJIMA, T., Nishimura, H., Sakamaki, J.-I., Komatsu, M., & Ikeda, F. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.20.700516 · Cited by 1
The dynamic nature of amyloid-beta protein aggregation and its association to Alzheimer’s disease
Vilaprinyó-Pascual, S. (2015) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Reporters of Amyloid Structure
LeVine, H. (2006) · Springer eBooks · doi:10.1007/0-387-25919-8_14
Development and Application of Mass Spectrometry-Based Biophysical Approaches
Zhang, Y. (2014) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7154f6v
Small Molecule Interactions with Self-Assembling Peptides
Seh, H. Y. (2011) · Deep Blue (University of Michigan)
Formation of abnormally large-sized tubular amyloid β aggregates on a nanostructured gold surface
Lee, J., Park, J., Kwak, B. K., Choi, I., Kim, Y., Choi, K., & Yi, J. (2010) · Korean Journal of Chemical Engineering · doi:10.1007/s11814-010-0314-4
The involvement of degradation pathways and neuron-to-neuron transmission in Alzheimer’s disease
Agholme, L. (2012) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Affibody molecules for proteomic and therapeutic applications
Grönwall, C. (2008) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Östner, G. (2013) · Lund University Publications (Lund University)
Wang, Y.-C., Huang, R., Wu, S.-D., & Shan, C. (2009)
AFM detection of an Alzheimer marker: Different stages of amyloid beta peptide on a mica substrate
Lee, J., Jeong, H., Bubar, C. T., BUSNAINA, A. A., & Lee, H. (2015) · Journal of the Korean Physical Society · doi:10.3938/jkps.67.1957
Pathological Consequences of Aβ From Extracellular to Intraneuronal
D’Andrea, M. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804256-4.00004-8
Merlin, J. L. P. (2013) · Journal of the Chosun Natural Science · doi:10.13160/ricns.2013.6.4.220
Studying Amyloid b-Protein Assembly
Maji, S. K., Lazo, N. D., Fradinger, E. A., & Teplow, D. B. (2004) · CRC Press eBooks · doi:10.1201/9780203492185.ch7
Intraneuronal Amyloid and Plaque Formation
D’Andrea, M. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804256-4.00005-x
Plasma decontamination of surfaces
Kong, M. G., & Laroussi, M. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511902598.010
Identifying the mechanism of Aβ42 inhibition of PDGF-BB signalling
Saffi, G. T. (2014) · UWSpace (University of Waterloo)
Neuron-to-neuron propagation of neurodegenerative proteins; relation to degradative systems
Domert, J. (2017) · Linköping University medical dissertations · doi:10.3384/diss.diva-134667
Detection and conformational characterization of misfolded proteins in neurodegenerative diseases
Morozova, O. A. (2016) · Library, Museums and Press - UDSpace (University of Delaware) · doi:10.58088/yt52-dk03
Nitrate Chimeras: A New Class of Disease Modifying Agents for the Treatment of Alzheimer's Disease
VandeVrede, L. A. (2014) · Figshare
In Vitro Characterization of Unmodified and Pyroglutamylated Alzheimer's Amyloid beta peptide
Matos, J. O. (2014) · Journal of International Crisis and Risk Communication Research
Electroanalysis of α-Synuclein Aggregation Related to Parkinson's Disease
Chan, T. (2011) · TSpace (University of Toronto)
Feng, L. (2019) · Research Online (University of Wollongong)
Effects of anle138b treatment on amyloid-β neurotoxicity
Thomas, C. (2020) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8233
Aβ promotes amyloidogenic processing of APP through a Go/Gβγ signalingPreprint
Antonino, M., Marmo, P., Freites, C. L., Quassollo, G., Sánchez, M. F., Lorenzo, A., & Bignante, E. A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.10.434768
Engineering Sciences (Mechanical Engineering)
Conroy, D. T., Kastner, M., Lasheras, J. C., Reeburgh, W. S., Rottman, J. W., & Tartakovsky, D. M. (2008)
Biophysical Analysis of the Structure and Aggregation of Amyloid beta Peptide
Abedin, F. (2021) · Journal of International Crisis and Risk Communication Research
Yang, X., Chen, Y.-H., Liu, L., Gu, Z., You, Y., Hao, J., Sun, N., & Gao, C. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4527346
de Dios, C., Abadin, X., Agujetas, V. R., Jiménez-Martínez, M., Morales, A., Trullás, R., Marı́, M., & Colell, A. (2023) · Figshare · doi:10.6084/m9.figshare.22626457
Altered T cell reactivity to β-amyloid-related antigens in early Alzheimer’s diseasePreprint
Rickenbach, C., Mallone, A., Häusle, L., Frei, L., Seiter, S., Sparano, C., Kirabali, T., Blennow, K., Zetterberg, H., Ferretti, M. T., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.04.597424
Farnum, Z., Mani, R., Bindoff, A. D., Wilson, R., Fiotakis, A., Stephens, J., Cho, H., Mackay‐Sim, A., & Sinclair, D. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16263
Zahraee, H., Arab, S. S., Parvaee, E., Mohammadi, F., Abnous, K., Taghdisi, S. M., & Khoshbin, Z. (2024) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2024.126658
Preparation and NMR characterization of Aβ peptides at pathological pH
He, X., Ma, Y., Zhang, N., & Zhou, C. (2025) · Protein Expression and Purification · doi:10.1016/j.pep.2025.106704
Reza-Zaldívar, E. E., Faccinetto-Beltrán, P., & Jacobo‐Velázquez, D. A. (2025) · CyTA - Journal of Food · doi:10.1080/19476337.2025.2526636
Sunkara, S., Krishnamoorthy, R., Radulović, S., Leoni, M., Patz, S., Goessler, W., Kaufmann, W. A., Birkl-Toeglhofer, A. M., Haybaeck, J., & Leitinger, G. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.11.664035
de Oliveira, T. B., Galeriani, A. C. B., de Souza, J. R. R., Kawano, D. F., Trevisan, M. T. S., & Almeida, W. P. (2025) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgaf055
Liu, H. (2012) · UWSpace (University of Waterloo)
Bao, Y., Yang, X., Fu, Y., Zhengyan, L., Gong, R., & Lu, W. (2021) · Figshare · doi:10.6084/m9.figshare.16590459
Dou, Y., Xie, J., Tan, Y., Zhang, M., Zhao, Y., & Liu, X. (2021) · Figshare · doi:10.6084/m9.figshare.16821559
Dou, Y., Xie, J., Tan, Y., Zhang, M., Zhao, Y., & Liu, X. (2021) · Figshare · doi:10.6084/m9.figshare.16821562
Dou, Y., Xie, J., Tan, Y., Zhang, M., Zhao, Y., & Liu, X. (2021) · Figshare · doi:10.6084/m9.figshare.16821565
Dou, Y., Xie, J., Tan, Y., Zhang, M., Zhao, Y., & Liu, X. (2021) · Figshare · doi:10.6084/m9.figshare.16821547
Luibl, V. (2006) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.5701
Dou, Y., Xie, J., Tan, Y., Zhang, M., Zhao, Y., & Liu, X. (2021) · Figshare · doi:10.6084/m9.figshare.16821550
de Dios, C., Abadin, X., Agujetas, V. R., Jiménez-Martínez, M., Morales, A., Trullás, R., Mari, M., & Colell, A. (2023) · Figshare · doi:10.6084/m9.figshare.22626454
Dou, Y., Xie, J., Tan, Y., Zhang, M., Zhao, Y., & Liu, X. (2021) · Figshare · doi:10.6084/m9.figshare.16821553
Dou, Y., Xie, J., Tan, Y., Zhang, M., Zhao, Y., & Liu, X. (2021) · Figshare · doi:10.6084/m9.figshare.16821556
Riluzole shifts glial responses to protect synapses and memory in Aβ oligomer–treated ratsPreprint
Wint-Mon, M.-K., Kida, H., Kimura, R., & Mitsushima, D. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.26.696626
Systemic Amyloid-β Metabolism in Alzheimer’s Disease
Dong-yu, F., Wang, J., Gu, B. J., Masters, C. L., & Wang, Y. (2026) · Springer eBooks · doi:10.1007/978-981-95-5222-1_7
Prieur, M., Hemonnot-Girard, A.-L., Beck, V., Garcia, V., Phuadraksa, T., Linck, N., Leportier, M., Vignon, A., Séverac, D., Perrier, V., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.28.702259
Chauhan, M., Singh, K. P., & Sharma, P. (2026) · iScience · doi:10.1016/j.isci.2026.115181
Etude préclinique et clinique de la phase précoce de la maladie d'Alzheimer
Epelbaum, S. (2015) · theses.fr (ABES) · doi:10.70675/ea81e5c2z5032z4474z9f96z59f62125a629
Halim, M. A. (2017) · theses.fr (ABES) · doi:10.70675/1987b0d6z615ez491dz9468z6cb2816294cf
Gu, L., Sun, D., Sun, L., Ma, T., Wang, Q., Hou, X., & Cheng, H. (2026) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukaryotgeneexpr.2026064685
Wan, X., Lu, W., Liu, S., Zhao, Y., Hu, J., Ding, X., Gu, P., Zou, Y., Jiang, B., & Yang, Y. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.05.341
Kafi, M. A. A., Passalacqua, M., Villa, V., Thellung, S., Corsaro, A., Grimaldi, R., Spatola, E., Florio, T., Baldelli, P., & Ricciarelli, R. (2026) · Neurotherapeutics · doi:10.1016/j.neurot.2026.e00941
Amyloid beta aggregation seeding activity as a new biomarker for Alzheimer’s disease
Song, Y., Xie, S., Li, T. Y., Li, Y., Nie, S., Wang, Z., Ma, J., & Jia, J. X. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004142
Fagla, B. M., Zhao, G., Valencia‐Olvera, A. C., Weng, J. M., Rosa, C. D., Ticiani, E., Tai, L. M., Veiga-Lopez, A., & Buhimschi, I. A. (2026) · Placenta · doi:10.1016/j.placenta.2026.06.015
Bolon, M., Barbereau, A., Aimard, M., Monge, C., Bouvet, P., Meissirel, C., & Richard, S. (2026) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2026.102987
Shrinking of Extracellular Space During Metabolic Stress Accelerates Amyloid-β Aggregation
Oliveira, L. F. D., Karunarathne, K., Zona, D., Muschol, M., & Ullah, G. (2026) · Biomolecules · doi:10.3390/biom16071053
Ren, X., Jin, X., Li, L., & Li, F. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1889254
Metadata
- Authors
- Stine, W. B., Dahlgren, K. N., Krafft, G. A., & LaDu, M. J.
- Affiliations
- Northwestern University (US)
- Corresponding author
- LaDu, Mary Jo
- ORCID
- LaDu, Mary Jo
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-03
- Volume
- 278
- Issue
- 13
- Pages
- 11612-11622
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2133631618
- Cited by
- 1,015
- References
- 74
- Citations by year
- 2026: 40 · 2025: 39 · 2024: 37 · 2023: 39 · 2022: 34 · 2021: 49 · 2020: 37 · 2019: 40 · 2018: 33 · 2017: 46 · 2016: 49 · 2015: 42 · 2014: 60 · 2013: 52 · 2012: 69
- FWCI
- 19.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Alzheimer's Association
- Northwestern University
- National Institutes of Health (1p01ag015501-01, 5r01ag013496-05)
- National Institute on Aging (R01AG019121, AG-15501, AG 19121, AG13496)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta, amyloid-beta 42, oligomerization, fibril formation, Alzheimer's disease, neurotoxicity, peptide aggregation, solution conditions, familial Alzheimer's disease mutations, amyloid plaques, peptide conformation
- MeSH terms
- Biopolymers, Circular Dichroism, Electrophoresis, Polyacrylamide Gel, Peptide Fragments, Solubility, Blotting, Western, Amyloid beta-Peptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review